tigating the protein turnover rates in premature infants were studied in nine human milk-fed neonates (born after 32 to 34 wk of gestation) by paired comparison of the tracers. The IsN enrichment of total urinary nitrogen and ammonia after administration of a single oral dose of ISN was measured by emission spectrometry. Flux rates were calculated using a three-compartment model and the ammonia end product method. The mean whole-body protein synthesis rates, as determined by the three-compartment model derived from the three I5N tracers, differed signifi-
as tracers for investigating the protein turnover rates in premature infants were studied in nine human milk-fed neonates (born after 32 to 34 wk of gestation) by paired comparison of the tracers. The IsN enrichment of total urinary nitrogen and ammonia after administration of a single oral dose of ISN was measured by emission spectrometry. Flux rates were calculated using a three-compartment model and the ammonia end product method. The mean whole-body protein synthesis rates, as determined by the three-compartment model derived from the three I5N tracers, differed significantly (p < 0.01) among ["Nlglycine (15.9 g/kg/d), [lSN] leucine (9.1 g/kg/d), and "N-YFTH (5.9 g/kg/d). When the corresponding rates were determined from the excretion of label in ammonia, the results showed the opposite tendency; the lowest apparent synthesis rates were found after [lsN]glycine (7. There is currently general confusion with regard to protein turnover analysis in preterm infants. This confusion may be attributed to the fact that there is considerable methodologic variation in the analytical methods used. Different tracers may be used, e.g. [ (8, 9) , 15N-amino acid mixtures (lo), 15N-yeast protein pepsin-trypsin hydrolysate (1 l), and 15N-yeast protein acid hydrolysate (12 (5, 7, 11, 12) . Finally, there are different ways of calculating the protein turnover rates in preterm infants, including the approach described by Picou and Taylor-Roberts (14) [modified by Steffee et al. (15) ], the model of Waterlow et al. (16) , the plasma method of Matthews et al. (1 7) , and the compartment model developed by Winkler and Faust (1 8) .
Most of the papers published do not take into consideration that the tracer must be representative of the protein metabolism (1 9); this is one of the basic requirements to be met by substances used as tracers in the investigation of parameters of the wholebody protein metabolism in preterm infants. Despite many theoretical and practical objections raised in relation to this requirement, [15N]glycine probably still continues to be the most commonly used tracer (2, (4) (5) (6) 20) . Although ["Nlglycine appears to satisfy the requirement when used in adults, it manifestly fails to do so in the case of those infants born prematurely; reported synthesis rates range between 6.1 and 23.3 g/kg/d (1) (2) (3) (4) .
Extremely high protein turnover rates found using [I5N]glycine in preterm infants led Jackson et al. (4) to the conclusion that glycine is semiessential in character in this age group. Mixtures of fully labeled amino acids (10) might be an alternative to [15N] glycine, but the prohibitive cost precludes widespread use. 15N-labeled yeast protein and its pepsin-trypsin hydrolysate, which might be an alternative to these expensive amino acid mixtures, are poorly absorbed (1 1). The almost complete enzymatic breakdown of I5N-yeast protein all the way down to the tripeptide, dipeptide, and amino acid level with thermitase, as recommended by our group (I I), seems to hold promise for further improvement.
Several authors (5, 12) claim that the end product method with [15N]ammonia as the final metabolite is suitable for assessing the whole-body protein parameters in this age group; they emphasize the ensuing benefits, such as reproducibility, fast urine collection, rapid monitoring, and minimal invasion. The main drawback of this approach is that it has not yet been validated by comparing it to conventional compartment methods as applied to the same subject.
The objective of the present study is, therefore, to investigate the protein turnover rates by paired comparison between preterm neonates after labeling with three different I5N-tracers (YPTH, leucine, and glycine) and two different methods, the TCM and abundance was 9 1.1 atom %, and the nitrogen content was 13.54 the AEPM. mg/100 mg (21) . The amino acid composion of the YPTH has been published previously (1 1).
MATERIALS AND METHODS
Subjects. Nine healthy, male, appropriate-for-gestational-age preterm infants were studied. Their mean weight at birth was 2028 + 158 g. Their post-conceptual and postnatal age was 33 + 1 wk and 18 k 3 d, respectively. Their body weight was 2146 +-244 g (glycine study), 2 137 t-186 g (leucine study), and 2 143 + 203g (YPTH study) ( Table 1 ). The infants were weighed daily. Four of the subjects had not yet fully regained their birth weight at the beginning of the study and during the initial tests (this was true of subject 1 during the glycine and leucine tests, of subject 2 during the glycine and YPTH tests, of subject 6 during the YPTH test, and of subject 8 during the glycine test; these were the respective initial tests performed according to the randomization principle). All infants were established for enteral HMF. With one exception (subject 2, glycine group), all infants were gaining weight during the study. The testing protocol was approved by the Committee on Ethics of the University of Rostock. All parents had given their consent for their children to be included in our study.
Feeding. All subjects were on HMF (pooled raw human milk collected from voluntary healthy donors in the 2nd to 12th wk of lactation). The mandatory quality tests were performed on every batch from each donor before the milk was added to the pool. After pooling, the milk was deep-frozen immediately. The food volume per subject and its nitrogen and energy content are shown in Table 2 . The HMF infants received the pooled human milk either by bottle feeding or by nasogastric tube. At the time of the study, all infants were being nursed in an incubator and had been free of any major clinical problems.
Analysis showed that the pooled human milk had a mean nitrogen content of 149.6 mmol/L (2.096 g/L), corresponding to a protein equivalent of 13.1 g/L. The calorimetric energy content, measured by anisothermic bomb calorimetry, was 2920.0 kJ/L (698 kcal/L).
Tracer substances. The tracer substances used in the experiments were [I5N]glycine (95.0 atom %), [15N]leucine (95.0 atom %), both manufactured by Berlin-Chemie, Germany, and 15N-YPTH. The latter was produced by hydrolyzing "N-yeast protein with the protease thermitase for 4 h at pH 7.5 and 55°C. The proportion of substrate to enzyme was approximately 200 to 1. After inactivation by heating to 10O0C, the insoluble sediment was removed by centrifugation and the supernatant was lyophilized. The degree of hydrolysis was 43%, the mean chain length being 2.44. The percentage of pure amino acids was 18%. I5N
Study protocol. In all cases, the three different tracers were dissolved in 2 mL of human milk. Each tracer was given as a single dose, by nasogastric tube, at 1400 h, immediatelGreceding a feed. The three stages of testing began on the infants' 14th, 18th, and 22nd d of life, respectively. On each of these days, one of the tracers was given, but the order in which the nine subjects received the I5N-tracer substances was determined by a permutation table (Table I ). The dosage of the tracer corresponded to a 15N excess of 2 mg I5N per kg body weight. None of the subjects regurgitated after receiving the tracer. Condom urinals were used to collect the urine 2, 4, 6, 8, 12, 16, 20, 24, 30 , and 36 h after administration of the tracer. The urine was removed from the collection bag immediately, acidified with 6 N to attain a pH of <2, and stored at -20°C until analysis. Urine passed immediately before the start of the next tracer administration was analyzed to determine the background abundance of I5N (baseline) remaining from the preceding test.
Feces were collected over 36 h, scraped from polyvinyl film, homogenized, and kept at -20°C for later analysis. Fecal I4N and I5N losses were subtracted from the total nitrogen intake and the 15N excess dose, respectively.
Analytical techniques. The nitrogen content of the urine, feces, and milk was determined by the Kjeldahl digestion method. The protein content of the milk was calculated by multiplying the total nitrogen by a factor of 6.25.
Ammonia was separated in microdiffusion vessels through 12-h diffusion, following alkalization of the urine with 6 N NaOH, and trapped in 0.1 M boric acid. This was followed by titration with 0.1 N HCl in the presence of Tashiro indicator.
The I5N enrichment of the total nitrogen in the urine and feces and the urinary ammonia was subsequently determined by emission spectrometry (NO1 6E; Central Institute of Isotope and Radiation Research, Leipzig, Germany). This procedure includes oxidation of the residual ammonium chloride from the Kjeldahl digestion to nitrogen gas using sodium hypobromide (22) .
TCM. Winkler and Faust's (18) open three-pool model was used to calculate the parameters of the protein metabolism, e.g. protein synthesis, protein breakdown, and protein turnover, using a factor of 6.25 for conversion.
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The kinetics of nitrogen after a single oral dose is therefore described by the following equations: Fig. 1 . Fitted cumulative urinary I5N excretion curves. q1 = q1(0)e-(k2~+k3~)t the corrected curve obtained if q3 (t = infinity) is equated to the observed value for q3 at 48 h. The difference between the observed and corrected curves represents the recycling of tracer. This approach, which has been suggested by Waterlow et al. (1 6 ) is a reasonable compromise. The three pool model is shown in Figure 2 . The inflow of nutrient into the nonprotein nitrogen pool (metabolic pool) is denoted by I. Some of this is used for protein synthesis (S), and In these equations, ql(0) is the amount of tracer in the nonprotein nitrogen pool ql at t = 0. Therefore, ql(0) is the excess dose of I5N and is 100% at t = 0. The quantities q2 and q3 are, respectively, the amount of tracer dose in the protein pool and the cumulative renal excretion of excess I5N up to time t. The following parameters of protein turnover are, therefore: (1 -E) Reutilization rate (R) = 100 -Q AEPM. In addition to using the TCM, we measured protein turnover in preterm infants by examining the labeling of urinary ammonia after a single oral dose, as described by Waterlow et al. (1 6 ) and other authors (1 2, 24). I5N (mg) .24, a is the I5N abundance in NH3 (mg I5N/mg total N), and t is the collection time (h).
Protein synthesis (S) and breakdown (B) were determined in the same way as in the TCM:
RESULTS
Clinical details, nitrogen, and energy supply (Tables 1 and 2 ). The infants were closely matched for birth weight and gestational age. There were no statistical differences in weight at the time of testing, weight gain during testing, intake of human milk, or nitrogen and energy supply among all the tracer groups (27 separate test events).
Urinary and fecal excretion ( Table 3) . Given these practically identical conditions, the renal excretion percentages of the three different tracer substances were glycine, 2.8%; leucine, 3.4%; and YPTH, 5.4%. Renal I5N excess excretion increased from glycine to leucine to YPTH, with statistically significant differences between glycine and YPTH ( p < 0.05). Fecal excretion for the different I5N tracers was glycine, 0.6%; leucine, 0.9%; and YPTH, 2.2%. We found significant differences between glycine and YPTH ( p < 0.001) and between leucine and YPTH ( p < 0.01). Figures 3 and 4 show the 15N enrichment, measured in atom percent excess in ammonia nitrogen and total nitrogen.
Rate constants (Table 4 ). The rate constants for renal nitrogen Reutilization rates and half-life periods (Table 5) . We observed the highest reutilization rates after administration of glycine (97.3%), and the lowest were seen after YPTH (93.5%) (glycine vs leucine, p < 0.05; glycine vs YPTH, p < 0.01).
The half-life periods of I5N in the nonprotein nitrogen pool were significantly ( p < 0.01) shorter after administration of glycine (7.2 h) than after leucine (12.5 h) or YPTH (13.6 h).
Protein synthesis and breakdown rates ( Table 6 ). The calcu- When the vrotein synthesis rates were derived from the AEPM, Q Q Q the differences did not agree with the values obtained using the TCM; on the contrary, their rank order was reversed. We found the lowest values for glycine (7. showed the expected overestimation derived from the lower I5N enrichment of total nitrogen in all "N tracers (Table 7) . Any interference of I5N recycling from protein breakdown between the first and the third study was negligible, as shown by the natural urinary I5N abundance at the onset of the next study. F l u rates and net protein gain (Table 8 ). The flux rates derived from the different tracers and both approaches had an effect of the same order of magnitude, whereas the net protein gain was practically the same for all tracer groups (1.89 to 1.99 g/kg/d). The use of the I5N-tracer technique for obtaining information relating to the protein metabolism is based on the assumption that the tracer is representative of the system as a whole (25) . The validity of the tracer used has been repeatedly questioned since the 1970s, when investigation of the protein metabolism in prematurely born infants was begun on the basis of different models of calculation (1-4, 6-9, 1 1, 12 ). At present, [15N]glycine is the most commonly used tracer, primarily because it is easily available commercially.
Especially for premature infants, there are principal objections to the use of ["Nlglycine. These children are in particular need of glycine for skeletal protein synthesis during the phases of relatively rapid growth between the 30th and 34th postconceptual weeks. Because the glycine supply is limited under HMF, a substantial part of the tracer is retained for protein synthesis, especially for incorporation within cartilage (with a glycine content of 24%). Under these conditions, protein turnover may be overrated because of a low level of urea labeling, urea being the final product of the protein metabolism.
In addition to glutamine, glycine participates in ammonia formation to a greater extent than other amino acids (26) . Furthermore, according to Matthews et al. (27) , the transamination of the glycine-I5NH2 group to other amino acids is very poor, with the exception of serine and glutamine/glutamate. We have tried to overcome these problems by using YPTH.
When considering the results obtained from the TCM, the differences among the three tracer groups become obvious: Administration of [I5N]glycine resulted in exaggerated estimates of up to 2.5 times the flux rate as compared to YPTH (15.4 g/kg/ d vs 6.3 g/kg/d; p < 0.001), as had been expected. This typical glycine response (overestimate of protein nitrogen turnover rate, protein synthesis rate, and protein breakdown rate, as seen in Tables 6 and 8 , significantly higher reutilization rates, and shorter half-life periods of I5N in the nonprotein pool) reflects the fact that glycine is additionally involved in the synthesis of cartilage, hemine, choline, purine, and hippuric acid. This assertion agrees well with the results of Golden et al. (28) .
If, however, the rates are calculated from the excretion of label in ammonia, the results are the exact opposite: The apparent rates of protein nitrogen turnover rate, protein synthesis rate, and protein breakdown rate derived from ammonia were about twice as high with YPTH as with glycine: protein nitrogen turnover rate with glycine, 7.9 g/kg/d; and protein nitrogen turnover rate with YPTH, 17.1 g/kg/d ( p < 0.001). Several investigators (4, 5, 16, 29) have observed lower flux, synthesis, and breakdown rates when analyzing ammonia rather than urea in the majority of children and infants when ["N]glycine was administered continuously or in a single dose.
These results do not agree with data recently published by Stack et al. (12) . After administration of ["Nlglycine and acid hydrolyzed I5N-yeast protein to three premature infants fed on human milk, the authors did not find any differences in protein turnover rates. The results of our study are not directly comparable to those of Stack et al. Our study groups differ in gestational age, postnatal age, body weight, and the number of subjects observed. The resultant ratios of both tracers on formula feeding of four premature infants were of approximately the same order of magnitude as the results from the present study: protein nitrogen turnover rate with [I5N]glycine, 13.8 g/kg/d; and protein nitrogen turnover rate with acid hydrolyzed I5N-yeast protein,
The main drawback of a yeast protein hydrolysate as used by Stack et al. (12) could be the destruction of some amino acids, e.g. glutami*e br tryptophan, through treatment with concen: trated acids. The conversion of the glutamine to glutamate induced by acid hydrolysis is suspected to reduce the urinary ammonia excretion rate. To avoid any decomposition of amino acids, we prefer safe enzymatic hydrolysis with thermitase, a protease from Thermoactinomyces vulgaris. The degree of absorption of "N from this short-chain peptidelamino acid mixture was only slightly lower (97.8%) than that from leucine (99.1 %) or from glycine (99.4%). The fecal loss was so low that the analysis of the feces becomes dispensable in determining the turnover rates in prematurely born infants.
Regardless of which of the different methods was used, the calculated protein nitrogen turnover, synthesis, and breakdown rates after administration of ['5N]leucine were always between the values derived for [ISN]glycine and ISN-YPTH (Tables 6 and  8) .
Labeled leucine has commonly been used as a "representative" amino acid (19, 25) . One of the indispensable amino acids, leucine is preferably transaminated via a-ketoglutarate and glutamic acid in the muscles, kidneys, and brain. Compared to glycine, ammonia formation from leucine is less intense. This might suggest that [15N]leucine is relatively model-independent.
Considerable differences in the flux rates obtained using a variety of tracers have also been reported by Fern et al. (30) , with either urea or ammonia as end product. To avoid discrepancies between calculated flux rates derived from urea or ammonia, the authors emphasize the use of arithmetics and harmonic end product averages. Comparison of the flux rates as well as the protein synthesis and breakdown rates calculated by AEMP and [lSN]glycine as tracer and by TCM and I5N-YPTH as tracer shows that there are practically no differences (Tables 6  and 8 ). However, this observation does not justify replacing the combination TCM/YPTH with AEPMIglycine. The disadvantages ofthe AEPM with [I5N]glycine are based on the assumption of the existence of a single metabolic pool. Meanwhile, however, it has been generally accepted that the precursor pool of ammonia is not representative of the precursor pool for protein synthesis (30, 31) .
Our results obtained with the ammonia-based calculation indicate preferential utilization of glycine nitrogen by the premature infant's kidneys for ammonia genesis (5). The relatively low protein synthesis rates (5.9 g/kg/d) derived from labeling the total nitrogen after administration of YPTH and using the TCM agree well with data (7.9 g/kg/d) recently published by Beaufrkre et al. (9) calculated by the plasma method with L-[l-13C]-leucine. Pencharz et al. (1 3) concluded that the premature infant needs an optimum ratio between the net protein gain and the lowest possible rate of synthesis, inasmuch as protein synthesis requires energy input. The use of I5N-YPTH is a way of avoiding overestimates of the protein turnover rate and major individual variations due to disproportionally high glycine amino nitrogen retention.
Considering the uniformity of our three tracer groups with respect to gestational age, postnatal age, and body weight, it can be assumed that the "real" protein turnover rates were similar in all infants. It is therefore to be suspected that the wide range of protein synthesis and breakdown rates as determined by the different tracers and models are to be considered methodologic errors. The major difficulty in assessing protein flux rates in preterm infants is the absence of an objective "gold standard" combination of tracers, techniques, models, and assumptions.
The results of this comparison substantiate the assumption that there are methodologic errors in connection with the use of different tracers and models for the calculation of whole-body protein parameters in preterm infants, with respect to the main requirement for tracer kinetic studies; the tracer nitrogen must be representative of total amino acid nitrogen (19, 25) . Seen in this light, mixtures of completely labeled amino acids such as YPTH may represent the most reliable tracer substance inasmuch as, on the basis of the data obtained with I5N-labeled YPTH and with total I5N as the end product, there was no major difference in the order of magnitude of the protein flux between preterm and full-term infants (32) .
